International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 4 , Pages 1054-1060 , 15 March 2010

Health-Related Quality of Life up to Six Years After 125I Brachytherapy for Early-Stage Prostate Cancer

  • Ellen M.A. Roeloffzen, M.D.

      Affiliations

    • Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
    • Corresponding Author InformationReprint requests to: Ellen Roeloffzen, M.D., Department of Radiation Oncology, University Medical Center Utrecht, Heidelberglaan 100, Utrecht 3584 CX The Netherlands. Tel: (+31) 88-755-8800; Fax: (+31) 88-755-5850
    • ,
  • Irene M. Lips, M.D.

      Affiliations

    • Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
    • ,
  • Marion P.R. van Gellekom, Ph.D.

      Affiliations

    • Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
    • ,
  • Joep van Roermund, M.D.

      Affiliations

    • Department of Urology, University Medical Center Utrecht, Utrecht, The Netherlands
    • ,
  • Steven J. Frank, M.D.

      Affiliations

    • Department of Radiation Oncology, M. D. Anderson Medical Center, Houston, TX
    • ,
  • Jan J. Battermann, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
    • ,
  • Marco van Vulpen, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands

Received 10 February 2009 ,Revised 11 March 2009 ,Accepted 16 March 2009.

References 

  1. Grimm PD, Blasko JC, Sylvester JE, et al. 10-Year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy. Int J Radiat Oncol Biol Phys. 2001;51:31–40
  2. Battermann JJ, Boon TA, Moerland MA. Results of permanent prostate brachytherapy: 13 years of experience at a single institution. Radiother Oncol. 2004;71:23–28
  3. Zelefsky MJ, Kuban DA, Levy LB, et al. Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. Int J Radiat Oncol Biol Phys. 2007;67:327–333
  4. Potters L, Morgenstern C, Calugaru E, et al. 12-Year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer. J Urol. 2008;179:S20–S24
  5. Peschel RE, Colberg JW. Surgery, brachytherapy, and external-beam radiotherapy for early prostate cancer. Lancet Oncol. 2003;4:233–241
  6. Lee WR, McQuellon RP, Harris-Henderson K, et al. A preliminary analysis of health-related quality of life in the first year after permanent source interstitial brachytherapy (PIB) for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2000;46:77–81
  7. Brandeis JM, Litwin MS, Burnison CM, et al. Quality of life outcomes after brachytherapy for early stage prostate cancer. J Urol. 2000;163:851–857
  8. Merrick GS, Butler WM, Wallner KE, et al. Long-term urinary quality of life after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2003;56:454–461
  9. Downs TM, Sadetsky N, Pasta DJ, et al. Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer—Data from CaPSURE. J Urol. 2003;170:1822–1827
  10. Feigenberg SJ, Lee WR, Desilvio ML, et al. Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05. Int J Radiat Oncol Biol Phys. 2005;62:956–964
  11. Caffo O, Fellin G, Bolner A, et al. Prospective evaluation of quality of life after interstitial brachytherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2006;66:31–37
  12. Stone NN, Stock RG. Long-term urinary, sexual, and rectal morbidity in patients treated with iodine-125 prostate brachytherapy followed up for a minimum of 5 years. Urology. 2007;69:338–342
  13. Frank SJ, Pisters LL, Davis J, et al. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer. J Urol. 2007;177:2151–2156
  14. Litwin MS, Gore JL, Kwan L, et al. Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer. 2007;109:2239–2247
  15. Ash D, Bottomley D, Al Qaisieh B, et al. A prospective analysis of long-term quality of life after permanent I-125 brachytherapy for localised prostate cancer. Radiother Oncol. 2007;84:135–139
  16. Miller DC, Sanda MG, Dunn RL, et al. Long-term outcomes among localized prostate cancer survivors: Health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J Clin Oncol. 2005;23:2772–2780
  17. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–376
  18. Penson DF. Quality of life after therapy for localized prostate cancer. Cancer J. 2007;13:318–326
  19. Litwin MS, Lubeck DP, Henning JM, et al. Differences in urologist and patient assessments of health related quality of life in men with prostate cancer: Results of the CaPSURE database. J Urol. 1998;159:1988–1992
  20. Henderson A, Andreyev HJ, Stephens R, et al. Patient and physician reporting of symptoms and health-related quality of life in trials of treatment for early prostate cancer: Considerations for future studies. Clin Oncol (R Coll Radiol). 2006;18:735–743
  21. Sloan JA, Frost MH, Berzon R, et al. The clinical significance of quality of life assessments in oncology: A summary for clinicians. Support Care Cancer. 2006;14:988–998
  22. van Gellekom MPR, Moerland MA, van Vulpen M, et al. Quality of life of patients after permanent prostate brachytherapy in relation to dosimetry. Int J Radiat Oncol Biol Phys. 2005;63:772–780
  23. Ash D, Flynn A, Battermann J, et al. ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. Radiother Oncol. 2000;57:315–321
  24. Nath R, Anderson LL, Luxton G, et al. Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine. Med Phys. 1995;22:209–234
  25. Hornbrook MC, Goodman MJ. Assessing relative health plan risk with the RAND-36 health survey. Inquiry. 1995;32:56–74
  26. Borghede G, Sullivan M. Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy: Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30. Qual Life Res. 1996;5:212–222
  27. Osoba D, Bezjak A, Brundage M, et al. Analysis and interpretation of health-related quality-of-life data from clinical trials: Basic approach of the National Cancer Institute of Canada Clinical Trials Group. Eur J Cancer. 2005;41:280–287
  28. van Andel G, Bottomley A, Fossa SD, et al. An international field study of the EORTC QLQ-PR25: A questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur J Cancer. 2008;44:2418–2424
  29. Talcott JA, Clark JA, Stark PC, et al. Long-term treatment related complications of brachytherapy for early prostate cancer: A survey of patients previously treated. J Urol. 2001;166:494–499
  30. Merrick GS, Butler WM, Wallner KE, et al. Long-term rectal function after permanent prostate brachytherapy. Cancer J. 2007;13:95–104
  31. Stock RG, Stone NN, Iannuzzi C. Sexual potency following interactive ultrasound-guided brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 1996;35:267–272
  32. Potters L, Torre T, Fearn PA, et al. Potency after permanent prostate brachytherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2001;50:1235–1242
  33. de Graeff A, de Leeuw JR, Ros WJ, et al. Long-term quality of life of patients with head and neck cancer. Laryngoscope. 2000;110:98–106

 Note—An online CME test for this article can be taken at http://asro.astro.org under Continuing Education.

 Conflict of interest: none.

PII: S0360-3016(09)00509-4

doi: 10.1016/j.ijrobp.2009.03.045

International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 4 , Pages 1054-1060 , 15 March 2010

Article Tools

* Image Usage & Resolution